The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Dec. 31, 2024

Filed:

Jun. 22, 2023
Applicant:

Adaptimmune Limited, Abingdon, GB;

Inventors:

Nicholas Tribble, Abingdon, GB;

William Lawrance, Abingdon, GB;

Eleanor Bagg, Abingdon, GB;

Assignee:

Adaptimmune Limited, Abingdon, GB;

Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
C07K 14/725 (2006.01); A61K 35/17 (2015.01); A61K 38/00 (2006.01); A61K 38/17 (2006.01); A61P 35/00 (2006.01); C07K 14/47 (2006.01); G01N 33/53 (2006.01);
U.S. Cl.
CPC ...
C07K 14/7051 (2013.01); A61K 35/17 (2013.01); A61P 35/00 (2018.01); C07K 14/4748 (2013.01); G01N 33/53 (2013.01); A61K 38/00 (2013.01); A61K 38/1774 (2013.01);
Abstract

The present invention relates to T cell receptors (TCRs) which bind the HLA-A*0201 restricted peptide GVYDGREHTV (SEQ ID NO: 1) derived from the MAGE-A4 protein. The TCRs of the invention demonstrate excellent specificity profiles for this MAGE epitope. Also provided are nucleic acids encoding the TCRs, cells engineered to present the TCRs, cells harbouring expression vectors encoding the TCRs and pharmaceutical compositions comprising the TCRs, nucleic acids or cells of the invention.


Find Patent Forward Citations

Loading…